FBXW7 promotes pathological cardiac hypertrophy by targeting EZH2-SIX1 signaling
Authors:
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 393 (1) , 112059
Abstract
No abstract availableKeywords
Funding Information
- Health Commission of Hebei Province (20190058)
This publication has 33 references indexed in Scilit:
- MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2Biochemical and Biophysical Research Communications, 2013
- Fbxw7 Controls Angiogenesis by Regulating Endothelial Notch ActivityPLOS ONE, 2012
- Transcription coactivator Eya2 is a critical regulator of physiological hypertrophyJournal of Molecular and Cellular Cardiology, 2012
- Polycomb Repressive Complex 2 Regulates Normal Development of the Mouse HeartCirculation Research, 2012
- Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasisNature Genetics, 2012
- Mechanisms of disease: hypertrophic cardiomyopathyNature Reviews Cardiology, 2011
- D-galactose induces necroptotic cell death in neuroblastoma cell linesJournal of Cellular Biochemistry, 2011
- Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liverJournal of Clinical Investigation, 2011
- The sine oculis homeobox (SIX) family of transcription factors as regulators of development and diseaseCellular and Molecular Life Sciences, 2008
- Cardiac PlasticityNew England Journal of Medicine, 2008